CME Group Inc. (NASDAQ:CME) Position Decreased by Cigna Investments Inc. New

Cigna Investments Inc. New decreased its holdings in shares of CME Group Inc. (NASDAQ:CMEGet Rating) by 27.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,621 shares of the financial services provider’s stock after selling 1,723 shares during the period. Cigna Investments Inc. New’s holdings in CME Group were worth $945,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the business. Massachusetts Financial Services Co. MA lifted its stake in CME Group by 132.0% during the first quarter. Massachusetts Financial Services Co. MA now owns 3,382,773 shares of the financial services provider’s stock valued at $804,626,000 after buying an additional 1,924,772 shares in the last quarter. Capital International Investors lifted its stake in CME Group by 8.4% during the first quarter. Capital International Investors now owns 14,292,196 shares of the financial services provider’s stock valued at $3,400,650,000 after buying an additional 1,104,075 shares in the last quarter. TD Asset Management Inc. lifted its stake in CME Group by 224.1% during the first quarter. TD Asset Management Inc. now owns 992,012 shares of the financial services provider’s stock valued at $235,960,000 after buying an additional 685,884 shares in the last quarter. Lord Abbett & CO. LLC purchased a new stake in CME Group during the first quarter valued at about $145,971,000. Finally, Renaissance Technologies LLC lifted its stake in CME Group by 208.9% during the second quarter. Renaissance Technologies LLC now owns 854,289 shares of the financial services provider’s stock valued at $174,873,000 after buying an additional 577,700 shares in the last quarter. Institutional investors own 85.56% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on CME shares. Deutsche Bank Aktiengesellschaft upped their price objective on shares of CME Group from $200.00 to $202.00 in a research note on Thursday, October 27th. Credit Suisse Group reduced their price target on shares of CME Group from $216.00 to $210.00 and set a “neutral” rating for the company in a research report on Tuesday, September 6th. StockNews.com started coverage on shares of CME Group in a research report on Wednesday, October 12th. They issued a “hold” rating for the company. Morgan Stanley reduced their price target on shares of CME Group from $213.00 to $208.00 and set an “equal weight” rating for the company in a research report on Thursday, October 27th. Finally, Citigroup started coverage on shares of CME Group in a research report on Tuesday, October 11th. They issued a “buy” rating and a $220.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $223.86.

CME Group Trading Up 1.3 %

NASDAQ:CME opened at $177.20 on Friday. The stock’s 50 day moving average price is $174.25 and its 200 day moving average price is $190.46. CME Group Inc. has a 52 week low of $166.58 and a 52 week high of $256.94. The company has a market capitalization of $63.74 billion, a P/E ratio of 24.11, a P/E/G ratio of 2.83 and a beta of 0.40. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CMEGet Rating) last released its quarterly earnings data on Wednesday, October 26th. The financial services provider reported $1.98 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.05. CME Group had a return on equity of 10.06% and a net margin of 54.01%. The firm had revenue of $1.23 billion for the quarter, compared to the consensus estimate of $1.23 billion. On average, research analysts forecast that CME Group Inc. will post 7.96 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 28th. Shareholders of record on Friday, December 9th will be issued a dividend of $1.00 per share. The ex-dividend date is Thursday, December 8th. This represents a $4.00 annualized dividend and a yield of 2.26%. CME Group’s dividend payout ratio (DPR) is presently 54.42%.

Insider Buying and Selling at CME Group

In other CME Group news, insider Ken Vroman sold 750 shares of the stock in a transaction that occurred on Monday, September 12th. The stock was sold at an average price of $201.41, for a total transaction of $151,057.50. Following the transaction, the insider now owns 12,486 shares in the company, valued at $2,514,805.26. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, Director William R. Shepard purchased 48,645 shares of the stock in a transaction on Friday, November 4th. The shares were bought at an average price of $170.00 per share, for a total transaction of $8,269,650.00. Following the completion of the acquisition, the director now directly owns 247,843 shares in the company, valued at approximately $42,133,310. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Ken Vroman sold 750 shares of the stock in a transaction that occurred on Monday, September 12th. The shares were sold at an average price of $201.41, for a total value of $151,057.50. Following the transaction, the insider now owns 12,486 shares in the company, valued at approximately $2,514,805.26. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

About CME Group

(Get Rating)

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEGet Rating).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.